Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

Lowering LDL cholesterol reduces the risk of developing atherosclerotic events in CKD, but the effects of such treatment on progression of kidney disease remain uncertain. Here, 6245 participants with CKD (not on dialysis) were randomly assigned to simvastatin (20 mg) plus ezetimibe (10 mg) daily or...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Haynes, Richard, Lewis, David, Emberson, Jonathan, Reith, Christina, Agodoa, Lawrence, Cass, Alan, Craig, Jonathan C., de Zeeuw, Dick, Feldt-Rasmussen, Bo, Fellström, Bengt, Levin, Adeera, Wheeler, David C., Walker, Rob, Herrington, William G., Baigent, Colin, Landray, Martin J., Tomson, Charles, Wanner, Christoph, Krane, Vera, Craig, Jonathan, Neal, Bruce, Jiang, Lixin, Hooi, Lai Seong, Gaziano, Mike, Kasiske, Bertram, Massy, Ziad A., Krairittichai, Udom, Ophascharoensuk, Vuddidhej, Holdaas, Hallvard, Tesar, Vladimir, Wiecek, Andrzej, Grobbee, Diederick, Grönhagen-Riska, Carola, Dasgupta, Tanaji, Herrington, Will, Mafham, Marion, Majoni, William, Wallendszus, Karl, Grimm, Richard, Pedersen, Terje, Tobert, Jonathan, Armitage, Jane, Baxter, Alex, Bray, Christopher, Chen, Yiping, Chen, Zhengming, Hill, Michael, Knott, Carol, Parish, Sarah, Simpson, David, Sleight, Peter, Young, Alan, Collins, Rory
Format: Artigo
Język:Inglês
Wydane: American Society of Nephrology 2014
Hasła przedmiotowe:
Clinical Epidemiology
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116066/
https://ncbi.nlm.nih.gov/pubmed/24790178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013090965
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy